Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment

L. Lores, M. C. Almendros, F. Ribò, T. Pascual, E. Arellano (Sant Boi de llobregat, Barcelona, Girona, Sant Boi, Barcelona, Spain)

Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea
Session: Cardiovascular and respiratory control in obstructive sleep apnoea
Session type: Thematic Poster Session
Number: 2040
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Lores, M. C. Almendros, F. Ribò, T. Pascual, E. Arellano (Sant Boi de llobregat, Barcelona, Girona, Sant Boi, Barcelona, Spain). Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment. Eur Respir J 2007; 30: Suppl. 51, 2040

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular risk markers in patients with OSA. Effects of CPAP treatment
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012


CPAP and measures of cardiovascular risks in patients with OSAS
Source: Eur Respir J 2009; 33: 1520
Year: 2009


Effects of CPAP treatment in UARS patients comparing to OSAS patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 320s
Year: 2007

Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


Predictors of compliance with CPAP in patients with OSA and metabolic syndrome
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


CPAP setting prediction in OSAS patients
Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea
Year: 2011

The effect of CPAP in asthma patients with SAHS
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Long-term effect of CPAP on systemic arterial hypertension development and control in a single cohort of 422 OSAH patients
Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Year: 2010

Assessment of efficiency of CPAP-therapy in patients with poor-controlled nocturnal asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 465s
Year: 2003

Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012



The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Weight and metabolic effects of CPAP in OSA patients with obesity
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010

Sleep apnoea and systemic hypertension
Source: Eur Respir Mon 2010; 50: 150-173
Year: 2010


No reduction of blood pressure with CPAP in non-sleepy hypertensive OSA patients
Source: ISSN=ISSN 1810-6838, ISBN=, page=193
Year: 2006

Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012


Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012